Connection

Daniel Steinberg to Immunosuppressive Agents

This is a "connection" page, showing publications Daniel Steinberg has written about Immunosuppressive Agents.
Connection Strength

0.177
  1. Percutaneous coronary intervention with second-generation paclitaxel-eluting stents versus everolimus-eluting stents in United States contemporary practice (REWARDS TLX Trial). Am J Cardiol. 2012 Oct 15; 110(8):1119-24.
    View in: PubMed
    Score: 0.079
  2. Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries. Am J Cardiol. 2007 Mar 01; 99(5):599-602.
    View in: PubMed
    Score: 0.054
  3. Clinical outcomes after implantation of small diameter (=2.5?mm) sirolimus- versus paclitaxel-eluting stents. Int J Cardiol. 2010 Sep 24; 144(1):105-7.
    View in: PubMed
    Score: 0.016
  4. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J. 2008 Aug; 29(15):1851-7.
    View in: PubMed
    Score: 0.015
  5. Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents. Am J Cardiol. 2007 Sep 15; 100(6):965-9.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.